Established a narrative that increased availability improves health outcomes and reduces costs
Introduction
Our client, a medium-sized pharmaceutical company, wanted strategic support to proactively quantify the conversion of their life-saving medication to over-the-counter availability. OTC availability ultimately increases access for patients but also raises implications for payers given broader availability.
The Problem
The transition poses challenges by increasing patient access while complicating payer dynamics and requiring a strategic approach to quantify utilization, costs, and value through health economics research.
Our Solution
- Developed a crisp, evidence-driven model to quantify potential changes in utilization patterns and costs
- Integrated HEOR data into user-friendly model supporting key messaging and value proposition around improvements in health outcomes and decreases in healthcare costs
- Strategic tool that was used to facilitate internal decision making and external communications
- Shepherded the medical and legal review process to ensure timely alignment and implementation
Value Delivered
We developed a user-friendly model that integrates health economics and outcomes research (HEOR) data with a clear design, enabling the measurement of healthcare resource utilization (HCRU) improvements and cost savings. This model effectively supports key messaging for diverse stakeholders, ensuring that the value of the medication is communicated clearly and convincingly.
